Statistics from Altmetric.com
ELI Lilly, the US-based healthcare company, announced on April 22 that it had reached an agreement to acquire Novartis Animal Health. In a statement, the company said that the US $5.4 billion all-cash transaction would strengthen and diversify its own animal health business, Elanco. It reported that, on completion of the acquisition, Elanco would become the second-largest animal health company in terms of global revenue.
Under the terms of the agreement, Lilly will acquire all the assets of …
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.